Testing effectiveness (Phase 2)Study completedNCT04331795
What this trial is testing
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
Who this might be right for
COVID-19
University of Chicago 32